Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Completed Phase 3 Trials for Meningococcal Meningitis Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00474526A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants